ATRT-16. THE PI3K INHIBITOR PAXALISIB COMBINES SYNERGISTICALLY WITH THE MEK INHIBITOR MIRDAMETINIB TO TARGET ATYPICAL TERATOID/RHABDOID TUMORS

Atypical teratoid/rhabdoid tumors (AT/RT) are aggressive pediatric brain tumors and the most common malignant brain tumors of infancy. The four-year event-free survival rate is only 37%. There are limited treatment options for patients with relapsed AT/RT, but precision therapies may help improve su...

Descripción completa

Detalles Bibliográficos
Autores principales: Malebranche, Kristen, Findlay, Tyler, Geethadevi, Anupa, Eberhart, Charles, Raabe, Eric, Rubens, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: ATRT/Embryonal/ETMR - ATRT
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260004/
http://dx.doi.org/10.1093/neuonc/noad073.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260004/
http://dx.doi.org/10.1093/neuonc/noad073.016

Ejemplares similares